Cite
HARVARD Citation
Chen, H. et al. (2022). A 5-gene DNA methylation signature is a promising prognostic biomarker for early-stage cervical cancer. Journal of obstetrics and gynaecology. pp. 327-332. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Chen, H. et al. (2022). A 5-gene DNA methylation signature is a promising prognostic biomarker for early-stage cervical cancer. Journal of obstetrics and gynaecology. pp. 327-332. [Online].